Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hong Ge

Showing results (411-420 of 422) with videos related to

Pageof 43
Sort By:
Journal of Hematology & Oncology|December 7, 2025
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapyYi-Long Wu, Lin Wu, Nan Bi, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2025
Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching studyQi Liu, Junqiang Chen, Yuanji Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 23, 2021
Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung CancerLi Li, Shanshan Tang, Jiani C Yin, et al.
Human Genomics|January 5, 2019
Preimplantation genetic diagnosis and screening (PGD/S) using a semiconductor sequencing platformLi-Ya Wang, Xing-Qiang Rao, Yu-Qin Luo, et al.
JAMA Network Open|May 18, 2019
Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung CancerHaiyan Zeng, Rui Li, Chen Hu, et al.
Journal of the National Cancer Center|July 22, 2024
Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016Xin Wang, Fei Liang, Xiaomin Wang, et al.
BMC Cancer|March 8, 2024
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trialChengcheng Fan, Xu Wang, Xiaoli Zheng, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2025
Simultaneous Integrated Dose Reduction Radiation Therapy Versus Conventional Fractionated Radiation Therapy With Chemotherapy for Limited-Stage Small Cell Lung Cancer in the Modern Treatment Era: A Phase 3, Randomized Clinical Trial (SDR-RT trial)Tian-You Zhan, Tao Zhang, Wen-Qing Wang, et al.
Radiation Oncology (London, England)|June 10, 2021
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from ChinaXiao Chang, Wei Deng, Xin Wang, et al.
Cancer Communications (London, England)|August 20, 2024
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trialJian Zhang, Minghao Li, Kaixian Zhang, et al.
Pageof 43

Showing results (411-420 of 422) with videos related to

Sort By:
Pageof 43
Journal of Hematology & Oncology|December 7, 2025
PACIFIC-5: a phase III clinical trial of consolidation durvalumab in patients with unresectable stage III NSCLC and no progression after concurrent or sequential chemoradiotherapyYi-Long Wu, Lin Wu, Nan Bi, et al.
Cancer Immunology, Immunotherapy : CII|November 18, 2025
Comparative analysis of immunochemotherapy with versus without radiation therapy for stage IVB esophageal squamous cell carcinoma confined to non-regional nodal metastases: a multicenter propensity score matching studyQi Liu, Junqiang Chen, Yuanji Xu, et al.
International Journal of Radiation Oncology, Biology, Physics|December 23, 2021
Comprehensive Next-Generation Sequencing Reveals Novel Predictive Biomarkers of Recurrence and Thoracic Toxicity Risks After Chemoradiation Therapy in Limited Stage Small Cell Lung CancerLi Li, Shanshan Tang, Jiani C Yin, et al.
Human Genomics|January 5, 2019
Preimplantation genetic diagnosis and screening (PGD/S) using a semiconductor sequencing platformLi-Ya Wang, Xing-Qiang Rao, Yu-Qin Luo, et al.
JAMA Network Open|May 18, 2019
Association of Twice-Daily Radiotherapy With Subsequent Brain Metastases in Adults With Small Cell Lung CancerHaiyan Zeng, Rui Li, Chen Hu, et al.
Journal of the National Cancer Center|July 22, 2024
Quality of life and survival outcomes of patients with inoperable esophageal squamous cell carcinoma after definitive radiation therapy: A multicenter retrospective observational study in China from 2015 to 2016Xin Wang, Fei Liang, Xiaomin Wang, et al.
BMC Cancer|March 8, 2024
Consolidation chemotherapy after definitive concurrent chemoradiotherapy in patients with inoperable esophageal squamous cell carcinoma: a multicenter non-inferiority phase III randomized clinical trialChengcheng Fan, Xu Wang, Xiaoli Zheng, et al.
International Journal of Radiation Oncology, Biology, Physics|October 16, 2025
Simultaneous Integrated Dose Reduction Radiation Therapy Versus Conventional Fractionated Radiation Therapy With Chemotherapy for Limited-Stage Small Cell Lung Cancer in the Modern Treatment Era: A Phase 3, Randomized Clinical Trial (SDR-RT trial)Tian-You Zhan, Tao Zhang, Wen-Qing Wang, et al.
Radiation Oncology (London, England)|June 10, 2021
Interobserver variability in target volume delineation in definitive radiotherapy for thoracic esophageal cancer: a multi-center study from ChinaXiao Chang, Wei Deng, Xin Wang, et al.
Cancer Communications (London, England)|August 20, 2024
Concurrent chemoradiotherapyof different radiation doses and different irradiation fields for locally advanced thoracic esophageal squamous cell carcinoma: A randomized, multicenter, phase III clinical trialJian Zhang, Minghao Li, Kaixian Zhang, et al.
Pageof 43